Genetic polymorphisms of the angiotensin II type 1 receptor gene and diastolic heart failure

Journal of Hypertension

Volumn 27, Issue 3, 2009, Pages 502-507

  Wu, Cho Kai ^a   Tsai, Chia Ti ^a   Chang, Yi Cheng ^a   Luo, Jing Ling ^b   Wang, Yi Chih ^a   Hwang, Juey Jen ^a   Lin, Jiunn Lee ^a   Tseng, Chuen Den ^a   Chiang, Fu Tien ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b KEELUNG HOSPITAL   (Taiwan)

Author keywords

Angiotensin II type 1 receptor; Diastolic heart failure; Genetics; Polymorphism

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLE; ECHOCARDIOGRAPHY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HEART FAILURE; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 67649537528     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32831fda3a     Document Type: Article

References (27)

1. Chatterjee K, Massie B. Systolic and diastolic heart failure: differences and similarities. J Card Fail 2007; 13:569-576.
2. Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss CK, Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 1999; 33:1948-1955.
3. Brilla CG, PickR,Tan LB, JanickiJS, WeberKT. Remodelingoftherat rightand left ventricles in experimental hypertension. Circ Res 1990; 67:1355-1364.
4. Ju H, Scammel-La Fleur T, Dixon IM. Altered mRNA abundance of calcium transport genes in cardiac myocytes induced by angiotensin II. J Mol Cell Cardiol 1996; 28:1119-1128.
5. Friedrich SP, Lorell BH, Rousseau MF, Hayashida W, Hess OM, Douglas PS, et al. Intracardiac angiotensin-converting enzyme inhibition improves diastolic function in patients with left ventricular hypertrophy due to aortic stenosis. Circulation 1994; 90:2761-2771.
6. Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 2003; 362:777-781.
7. Chang YC, Chang TJ, Jiang YD, Kuo SS, Lee KC, Chiu KC, Chuang LM. Association study of the genetic polymorphisms of the transcription factor 7-like 2 (TCF7L2) gene and type 2 diabetes in the Chinese population. Diabetes 2007; 56:2631-2637.
8. Smilde TD, Zuurman MW, Hillege HL, van Veldhuisen DJ, van Gilst WH, van der Steege G, et al. Renal function dependent association of AGTR1 polymorphism (A1166C) and electrocardiographic left-ventricular hypertrophy. Am J Hypertens 2007; 20:1097-1103.
9. Kiliszek M, Burzynska B, StyczynskiG, MaciagM, Rabczenko D,Opolski G. A1166C polymorphismof the angiotensin AT1 receptor (AT1R) gene alters endothelial response to statin treatment. Clin Chem Lab Med 2007; 45:839-842.
10. Szolnoki Z, Havasi V, Talian G, Bene J, Komlosi K, Somogyvari F, et al. Angiotensin II type-1 receptor A1166C polymorphism is associated with increased risk of ischemic stroke in hypertensive smokers. J Mol Neurosci 2006; 28:285-290.
11. Cameron VA, Mocatta TJ, Pilbrow AP, Frampton CM, Troughton RW, Richards AM, Winterbourn CC. Angiotensin type-1 receptor A1166C gene polymorphism correlates with oxidative stress levels in human heart failure. Hypertension 2006; 47:1155-1161.
12. Angeja BG, Grossman W. Evaluation and management of diastolic heart failure. Circulation 2003; 107:659-663.
13. How to diagnose diastolic heart failure. European Study Group on Diastolic Heart Failure. Eur Heart J 1998; 19:990-1003.
14. Wang YC, Hwang JJ, Lai LP, Tsai CT, Lin LC, Katra R, Lin JL. Coexistence and exercise exacerbation of intraleft ventricular contractile dyssynchrony in hypertensive patients with diastolic heart failure. Am Heart J 2007; 154:278-284.
15. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58:1072-1083.
16. Quinones MA, Pickering E, Alexander JK. Percentage of shortening of the echocardiographic left ventricular dimension. Its use in determining ejection fraction and stroke volume. Chest 1978; 74:59-65.
17. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57:450-458.
18. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21:263-265.
19. Storm N, Darnhofer-Patel B, van den Boom D, Rodi CP. MALDI-TOF mass spectrometry-based SNP genotyping. Methods Mol Biol 2003; 212:241- 262.
20. Jurinke C, van den Boom D, Cantor CR, Koster H. The use of MassARRAY technology for high throughput genotyping. Adv Biochem Eng Biotechnol 2002; 77:57-74.
21. Purcell S, Cherny SS, Sham PC. Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003; 19:149-150.
22. Bursi F, Weston SA, Redfield MM, Jacobsen SJ, Pakhomov S, Nkomo VT, et al. Systolic and diastolic heart failure in the community. JAMA 2006; 296:2209-2216.
23. Tribouilloy C, Rusinaru D, Leborgne L, Peltier M, Massy Z, Slama M. Prognostic impact of angiotensin-converting enzyme inhibitor therapy in diastolic heart failure. Am J Cardiol 2008; 101:639-644.
24. Rapp JA, Gheorghiade M. Role of neurohormonal modulators in heart failure with relatively preserved systolic function. Cardiol Clin 2008; 26:23-40.
25. Cox NJ, Hayes MG, Roe CA, Tsuchiya T, Bell GI. Linkage of calpain 10 to type 2 diabetes: the biological rationale. Diabetes 2004; 53 (Suppl 1):S19-S25.
26. Matarin M, Brown WM, Hardy JA, Rich SS, Singleton AB, Brown RD Jr, et al. Association of integrin alpha2 gene variants with ischemic stroke. J Cereb Blood Flow Metab 2008; 28:81-89.
27. Colhoun HM, McKeigue PM, Davey Smith G. Problems of reporting genetic associations with complex outcomes. Lancet 2003; 361:865-872.